TNYA RSI Chart
Last 7 days
11.0%
Last 30 days
8.4%
Last 90 days
-26.3%
Trailing 12 Months
-35.5%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 05, 2024 | hoey timothy | sold | -23,101 | 7.0003 | -3,300 | chief scientific officer |
Feb 23, 2024 | tingley whittemore | acquired | - | - | 35,000 | chief medical officer |
Feb 23, 2024 | ali faraz | acquired | - | - | 85,000 | chief executive officer |
Feb 23, 2024 | hoey timothy | acquired | - | - | 12,500 | chief scientific officer |
Feb 23, 2024 | patterson leone d | acquired | - | - | 35,000 | chief fin. and bus. officer |
Feb 20, 2024 | hoey timothy | sold | -35,046 | 5.33506 | -6,569 | chief scientific officer |
Feb 16, 2024 | patterson leone d | sold | -30,477 | 5.86 | -5,201 | chief fin. and bus. officer |
Feb 16, 2024 | hoey timothy | sold | -27,430 | 5.86 | -4,681 | chief scientific officer |
Feb 16, 2024 | ali faraz | sold | -37,257 | 5.86 | -6,358 | chief executive officer |
Feb 16, 2024 | tingley whittemore | sold | -38,090 | 5.86 | -6,500 | chief medical officer |
Which funds bought or sold TNYA recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | JANE STREET GROUP, LLC | added | 293 | 267,945 | 317,974 | -% |
May 16, 2024 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -38.91 | -344 | 24,429 | -% |
May 15, 2024 | GOLDMAN SACHS GROUP INC | added | 10.24 | 188,115 | 429,446 | -% |
May 15, 2024 | TWO SIGMA ADVISERS, LP | reduced | -20.9 | 130,081 | 599,881 | -% |
May 15, 2024 | Jasper Ridge Partners, L.P. | unchanged | - | 20,398 | 53,608 | -% |
May 15, 2024 | Tower Research Capital LLC (TRC) | reduced | -57.78 | -5,493 | 11,757 | -% |
May 15, 2024 | CITADEL ADVISORS LLC | added | 12.31 | 5,270,600 | 11,754,500 | -% |
May 15, 2024 | RA CAPITAL MANAGEMENT, L.P. | added | 4.5 | 12,255,100 | 30,098,900 | 0.38% |
May 15, 2024 | MARSHALL WACE, LLP | sold off | -100 | -61,369 | - | -% |
May 15, 2024 | MILLENNIUM MANAGEMENT LLC | reduced | -25.38 | 333,132 | 1,961,780 | -% |
Unveiling Tenaya Therapeutics, Inc.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Tenaya Therapeutics, Inc.)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
Tenaya Therapeutics, Inc. News
Balance Sheet | ||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2020Q4 |
Assets | 8.4% | 185 | 171 | 193 | 221 | 245 | 279 | 226 | 256 | 281 | 314 | 332 | 157 | 148 |
Current Assets | 15.3% | 129 | 112 | 127 | 139 | 155 | 194 | 157 | 186 | 214 | 255 | 285 | 113 | 130 |
Cash Equivalents | 29.8% | 59.00 | 46.00 | 82.00 | 76.00 | 73.00 | 95.00 | 34.00 | 31.00 | 26.00 | 38.00 | 117 | 112 | 129 |
Net PPE | -4.3% | 41.00 | 43.00 | 45.00 | 47.00 | 49.00 | 51.00 | 52.00 | 53.00 | 49.00 | 43.00 | 31.00 | 25.00 | 17.00 |
Liabilities | -14.1% | 27.00 | 31.00 | 29.00 | 31.00 | 30.00 | 36.00 | 30.00 | 32.00 | 32.00 | 36.00 | 28.00 | 25.00 | 9.00 |
Current Liabilities | -15.7% | 19.00 | 23.00 | 19.00 | 21.00 | 19.00 | 24.00 | 18.00 | 19.00 | 19.00 | 22.00 | 14.00 | 10.00 | 5.00 |
Shareholder's Equity | 13.5% | 158 | 139 | 165 | 190 | 215 | 243 | 196 | 224 | 249 | 279 | 304 | - | - |
Retained Earnings | -8.0% | -435 | -403 | -373 | -344 | -310 | -279 | -245 | -215 | -186 | -155 | -129 | -111 | -82.81 |
Additional Paid-In Capital | 9.4% | 594 | 543 | 538 | 534 | 526 | 523 | 443 | 440 | 436 | 434 | 433 | 3.00 | 2.00 |
Shares Outstanding | -100.0% | - | 68.00 | 74.00 | 73.00 | 73.00 | 67.00 | 41.00 | 41.00 | 41.00 | 41.00 | 27.00 | - | 1.00 |
Float | - | - | - | - | 272 | - | - | - | 156 | - | 528 | - | - | - |
Cashflow (Quarterly) | |||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 |
Cashflow From Operations | -30.7% | -28,660 | -21,924 | -23,638 | -26,220 | -30,290 | -22,682 | -27,556 | -25,430 | -28,756 | -16,347 | -16,657 | -12,019 | -15,789 | - | - | - |
Share Based Compensation | 7.0% | 4,224 | 3,949 | 4,015 | 3,831 | 3,514 | 3,187 | 3,174 | 3,012 | 2,094 | 1,048 | 968 | 502 | 432 | - | - | - |
Cashflow From Investing | 69.9% | -4,489 | -14,919 | 30,488 | 25,085 | 8,061 | 5,974 | 31,034 | 30,210 | 16,434 | -62,580 | -168,425 | -3,236 | -4,323 | - | - | - |
Cashflow From Financing | 12506.7% | 46,771 | 371 | - | 4,179 | -501 | 77,486 | 6.00 | 260 | 15.00 | -21.00 | 190,274 | -1,298 | 20,015 | - | - | - |
Buy Backs | - | - | - | - | - | - | - | - | - | - | - | 3.00 | - | - | - | - | - |
Condensed Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Operating expenses: | ||
Research and development | $ 25,055 | $ 25,605 |
General and administrative | 8,707 | 8,118 |
Total operating expenses | 33,762 | 33,723 |
Loss from operations | (33,762) | (33,723) |
Other income, net: | ||
Interest income | 1,452 | 1,973 |
Other income, net | 82 | 13 |
Total other income, net | 1,534 | 1,986 |
Net loss before income tax expense | (32,228) | (31,737) |
Net loss | (32,228) | (31,737) |
Other comprehensive income (loss): | ||
Net unrealized gain (loss) on marketable securities | (14) | 258 |
Comprehensive loss | $ (32,242) | $ (31,479) |
Net loss per share, basic | $ (0.4) | $ (0.43) |
Net loss per share, diluted | $ (0.4) | $ (0.43) |
Weighted-average shares used in computing net loss per share, basic | 80,982,326 | 73,097,889 |
Weighted-average shares used in computing net loss per share, diluted | 80,982,326 | 73,097,889 |
Condensed Balance Sheets (Unaudited) - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 59,303 | $ 45,681 |
Short-term investments in marketable securities | 62,946 | 58,961 |
Prepaid expenses and other current assets | 6,450 | 6,940 |
Total current assets | 128,699 | 111,582 |
Property and equipment, net | 41,396 | 43,277 |
Operating lease right-of-use assets | 9,177 | 9,979 |
Other noncurrent assets | 5,627 | 5,677 |
Total assets | 184,899 | 170,515 |
Current liabilities: | ||
Accounts payable | 6,659 | 5,630 |
Accrued and other current liabilities | 8,435 | 12,784 |
Operating lease liabilities, current | 4,064 | 4,319 |
Total current liabilities | 19,158 | 22,733 |
Operating lease liabilities, noncurrent | 7,302 | 8,105 |
Other noncurrent liabilities | 259 | 253 |
Total liabilities | 26,719 | 31,091 |
Commitments and contingencies (Note 5) | ||
Stockholders' equity: | ||
Common stock | 8 | 7 |
Additional paid-in capital | 593,802 | 542,805 |
Accumulated other comprehensive loss | (120) | (106) |
Accumulated deficit | (435,510) | (403,282) |
Total stockholders' equity | 158,180 | 139,424 |
Total liabilities and stockholders' equity | $ 184,899 | $ 170,515 |